Cyp7a1 | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA] | CTD | PMID:31150632 |
Cyp7a1 | Rat | (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of CYP7A1 mRNA and epigallocatechin gallate results in increased expression of CYP7A1 protein | CTD | PMID:23146761 |
Cyp7a1 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP7A1 mRNA | CTD | PMID:36331819 |
Cyp7a1 | Rat | (24S)-24-hydroxycholesterol | increases metabolic processing | ISO | CYP7A1 (Homo sapiens) | 6480464 | CYP7A1 protein results in increased metabolism of 24-hydroxycholesterol | CTD | PMID:11013305 |
Cyp7a1 | Rat | (25R)-cholest-5-ene-3beta,26-diol | increases metabolic processing | EXP | | 6480464 | CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol | CTD | PMID:10882719 |
Cyp7a1 | Rat | (25R)-cholest-5-ene-3beta,26-diol | increases metabolic processing | ISO | CYP7A1 (Homo sapiens) | 6480464 | CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol | CTD | PMID:10882719 |
Cyp7a1 | Rat | (E)-thiamethoxam | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Thiamethoxam results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | affects expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | o and p'-DDT affects the expression of CYP7A1 mRNA | CTD | PMID:18925944 |
Cyp7a1 | Rat | 1,2-dichloroethane | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of CYP7A1 mRNA | CTD | PMID:28189721 and PMID:28960355 |
Cyp7a1 | Rat | 1,3,4-thiadiazole | affects expression | EXP | | 6480464 | 1 more ... | CTD | PMID:30905023 |
Cyp7a1 | Rat | 1,3,7,9-tetramethyluric acid | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:35872049 |
Cyp7a1 | Rat | 1,4-dithiothreitol | increases activity | EXP | | 6480464 | Dithiothreitol results in increased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA and 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein | CTD | PMID:14623915 more ... |
Cyp7a1 | Rat | 1-naphthyl isothiocyanate | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein | CTD | PMID:36787806 |
Cyp7a1 | Rat | 1-naphthyl isothiocyanate | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | 4-methyl-7 and 8-dihydroxycoumarin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein] | CTD | PMID:36581201 |
Cyp7a1 | Rat | 1-naphthyl isothiocyanate | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein | CTD | PMID:36581201 |
Cyp7a1 | Rat | 1-naphthyl isothiocyanate | decreases expression | EXP | | 15090803 | 1-naphthyl isothiocyanate decreases expression of Cyp7a1 protein in rat liver | RGD | |
Cyp7a1 | Rat | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CYP7A1 mRNA | CTD | PMID:20551477 more ... |
Cyp7a1 | Rat | 1-naphthyl isothiocyanate | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA and 1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein | CTD | PMID:25655198 more ... |
Cyp7a1 | Rat | 1-naphthyl isothiocyanate | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] more ... | CTD | PMID:25655198 more ... |
Cyp7a1 | Rat | 1-naphthyl isothiocyanate | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] and resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein] | CTD | PMID:25418378 |
Cyp7a1 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of CYP7A1 mRNA more ... | CTD | PMID:16606610 more ... |
Cyp7a1 | Rat | 17alpha-ethynylestradiol | decreases activity | EXP | | 6480464 | Ethinyl Estradiol results in decreased activity of CYP7A1 protein | CTD | PMID:11473529 and PMID:9869655 |
Cyp7a1 | Rat | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of CYP7A1 mRNA | CTD | PMID:16487557 more ... |
Cyp7a1 | Rat | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | 3 more ... | CTD | PMID:12963437 and PMID:16487557 |
Cyp7a1 | Rat | 17alpha-ethynylestradiol | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in decreased expression of CYP7A1 mRNA and Ethinyl Estradiol results in decreased expression of CYP7A1 protein | CTD | PMID:16606610 more ... |
Cyp7a1 | Rat | 17beta-estradiol | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of CYP7A1 mRNA | CTD | PMID:20106945 |
Cyp7a1 | Rat | 17beta-estradiol | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Estradiol results in increased expression of CYP7A1 mRNA and Estradiol results in increased expression of CYP7A1 protein | CTD | PMID:35802278 |
Cyp7a1 | Rat | 17beta-estradiol | affects expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Estradiol affects the expression of CYP7A1 mRNA | CTD | PMID:39298647 |
Cyp7a1 | Rat | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CYP7A1 mRNA | CTD | PMID:32145629 |
Cyp7a1 | Rat | 1H-pyrazole | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | pyrazole results in decreased expression of CYP7A1 mRNA | CTD | PMID:17945193 |
Cyp7a1 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:23756648 more ... |
Cyp7a1 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:20056577 and PMID:27291303 |
Cyp7a1 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 and PMID:33078840 |
Cyp7a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP7A1 mRNA | CTD | PMID:20106945 |
Cyp7a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP7A1 mRNA | CTD | PMID:32109520 |
Cyp7a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:23756648 more ... |
Cyp7a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP7A1 mRNA | CTD | PMID:26159488 |
Cyp7a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP7A1 mRNA | CTD | PMID:16054898 and PMID:21215274 |
Cyp7a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CYP7A1 mRNA | CTD | PMID:19770486 more ... |
Cyp7a1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CYP7A1 mRNA | CTD | PMID:21095216 |
Cyp7a1 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:25768209 |
Cyp7a1 | Rat | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 |
Cyp7a1 | Rat | 2,4,6-trinitrotoluene | affects expression | EXP | | 6480464 | Trinitrotoluene affects the expression of CYP7A1 mRNA | CTD | PMID:21346803 |
Cyp7a1 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 |
Cyp7a1 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of CYP7A1 mRNA | CTD | PMID:21346803 |
Cyp7a1 | Rat | 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA and [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased expression of CYP7A1 mRNA | CTD | PMID:14656948 and PMID:16158176 |
Cyp7a1 | Rat | 2-arachidonoylglycerol | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA] | CTD | PMID:23894352 |
Cyp7a1 | Rat | 2-arachidonoylglycerol | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA | CTD | PMID:23894352 |
Cyp7a1 | Rat | 2-arachidonoylglycerol | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | CNR1 gene mutant form inhibits the reaction [glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA] more ... | CTD | PMID:23894352 |
Cyp7a1 | Rat | 2-arachidonoylglycerol | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | glyceryl 2-arachidonate results in increased expression of CYP7A1 mRNA | CTD | PMID:23894352 and PMID:28095641 |
Cyp7a1 | Rat | 2-trans,6-trans,10-trans-geranylgeranyl diphosphate | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | geranylgeranyl pyrophosphate inhibits the reaction [resveratrol results in increased expression of CYP7A1 mRNA] | CTD | PMID:22607622 |
Cyp7a1 | Rat | 20-hydroxycholesterol | increases metabolic processing | EXP | | 6480464 | CYP7A1 protein results in increased metabolism of 20-hydroxycholesterol | CTD | PMID:10882719 |
Cyp7a1 | Rat | 20-hydroxycholesterol | increases metabolic processing | ISO | CYP7A1 (Homo sapiens) | 6480464 | CYP7A1 protein results in increased metabolism of 20-hydroxycholesterol | CTD | PMID:10882719 |
Cyp7a1 | Rat | 25-hydroxycholesterol | increases metabolic processing | ISO | CYP7A1 (Homo sapiens) | 6480464 | CYP7A1 protein results in increased metabolism of 25-hydroxycholesterol | CTD | PMID:10882719 |
Cyp7a1 | Rat | 25-hydroxycholesterol | increases metabolic processing | EXP | | 6480464 | CYP7A1 protein results in increased metabolism of 25-hydroxycholesterol | CTD | PMID:10882719 |
Cyp7a1 | Rat | 26-hydroxycholesterol | increases metabolic processing | ISO | CYP7A1 (Homo sapiens) | 6480464 | CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol | CTD | PMID:10882719 |
Cyp7a1 | Rat | 26-hydroxycholesterol | increases metabolic processing | EXP | | 6480464 | CYP7A1 protein results in increased metabolism of 27-hydroxycholesterol | CTD | PMID:10882719 |
Cyp7a1 | Rat | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | 3 more ... | CTD | PMID:23146750 |
Cyp7a1 | Rat | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:19467301 |
Cyp7a1 | Rat | 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluoro-1-decanol | affects expression | EXP | | 6480464 | fluorotelomer alcohols affects the expression of CYP7A1 mRNA | CTD | PMID:38903859 |
Cyp7a1 | Rat | 3-phenylprop-2-enal | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | cinnamaldehyde results in increased expression of CYP7A1 mRNA | CTD | PMID:19000754 |
Cyp7a1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of CYP7A1 mRNA | CTD | PMID:39298647 |
Cyp7a1 | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Cyp7a1 (Mus musculus) | 6480464 | bisphenol S affects the methylation of CYP7A1 gene | CTD | PMID:31683443 |
Cyp7a1 | Rat | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Cyp7a1 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of CYP7A1 exon | CTD | PMID:33297965 |
Cyp7a1 | Rat | 7,9-dihydro-1H-purine-2,6,8(3H)-trione | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [1-Naphthylisothiocyanate co-treated with Uric Acid] results in decreased expression of CYP7A1 mRNA | CTD | PMID:33749747 |
Cyp7a1 | Rat | 7-ketocholesterol | decreases activity | EXP | | 6480464 | 7-ketocholesterol results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | 7alpha-hydroxycholesterol | multiple interactions | EXP | | 6480464 | [Uranyl Nitrate results in decreased activity of CYP7A1 protein] which results in decreased chemical synthesis of cholest-5-en-3 beta and 7 alpha-diol | CTD | PMID:20362056 |
Cyp7a1 | Rat | 8-Epidiosbulbin E acetate | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | 8-epidiosbulbin E acetate results in decreased expression of CYP7A1 mRNA and 8-epidiosbulbin E acetate results in decreased expression of CYP7A1 protein | CTD | PMID:31626840 |
Cyp7a1 | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of CYP7A1 mRNA | CTD | PMID:15749267 |
Cyp7a1 | Rat | acrylamide | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Acrylamide results in decreased expression of CYP7A1 mRNA | CTD | PMID:34896238 |
Cyp7a1 | Rat | acrylamide | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | Acrylamide inhibits the reaction [Streptozocin results in increased expression of CYP7A1 mRNA] | CTD | PMID:34896238 |
Cyp7a1 | Rat | Actein | increases expression | EXP | | 6480464 | actein results in increased expression of CYP7A1 mRNA | CTD | PMID:19527300 |
Cyp7a1 | Rat | aflatoxin B1 | affects expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of CYP7A1 protein | CTD | PMID:20106945 |
Cyp7a1 | Rat | aflatoxin B1 | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of CYP7A1 mRNA and Aflatoxin B1 results in increased expression of CYP7A1 protein | CTD | PMID:37030333 |
Cyp7a1 | Rat | aflatoxin B1 | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | fexaramine inhibits the reaction [Aflatoxin B1 results in increased expression of CYP7A1 mRNA] | CTD | PMID:37030333 |
Cyp7a1 | Rat | aflatoxin B1 | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of CYP7A1 mRNA | CTD | PMID:22100608 and PMID:27153756 |
Cyp7a1 | Rat | aflatoxin B1 | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of CYP7A1 mRNA | CTD | PMID:19770486 |
Cyp7a1 | Rat | alfacalcidol | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | alfacalcidol results in increased expression of CYP7A1 mRNA | CTD | PMID:19581390 |
Cyp7a1 | Rat | all-trans-retinoic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tretinoin results in decreased expression of CYP7A1 mRNA] more ... | CTD | PMID:21274875 and PMID:30709899 |
Cyp7a1 | Rat | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CYP7A1 mRNA | CTD | PMID:24977338 |
Cyp7a1 | Rat | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with Ursodeoxycholic Acid] results in decreased expression of CYP7A1 mRNA | CTD | PMID:21274875 |
Cyp7a1 | Rat | all-trans-retinoic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CYP7A1 mRNA and Tretinoin results in decreased expression of CYP7A1 protein | CTD | PMID:21274875 and PMID:30709899 |
Cyp7a1 | Rat | allopurinol | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [1-Naphthylisothiocyanate co-treated with Allopurinol] results in decreased expression of CYP7A1 mRNA | CTD | PMID:33749747 |
Cyp7a1 | Rat | AM-251 | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | AM 251 inhibits the reaction [Ethanol results in increased expression of CYP7A1 mRNA] | CTD | PMID:23894352 and PMID:28095641 |
Cyp7a1 | Rat | amiodarone | decreases expression | EXP | | 6480464 | Amiodarone results in decreased expression of CYP7A1 mRNA | CTD | PMID:19224547 |
Cyp7a1 | Rat | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of CYP7A1 mRNA | CTD | PMID:22291062 |
Cyp7a1 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CYP7A1 mRNA | CTD | PMID:16483693 |
Cyp7a1 | Rat | amphibole asbestos | affects expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Asbestos and Amphibole affects the expression of CYP7A1 protein | CTD | PMID:20855422 |
Cyp7a1 | Rat | amphotericin B | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] and [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA | CTD | PMID:36464106 |
Cyp7a1 | Rat | ampicillin | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] more ... | CTD | PMID:36464106 and PMID:37211107 |
Cyp7a1 | Rat | angelicin | decreases expression | EXP | | 6480464 | angelicin results in decreased expression of CYP7A1 mRNA and angelicin results in decreased expression of CYP7A1 protein | CTD | PMID:30597224 |
Cyp7a1 | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [Tretinoin results in decreased expression of CYP7A1 mRNA] and pyrazolanthrone inhibits the reaction [Tretinoin results in decreased expression of CYP7A1 protein] | CTD | PMID:30709899 |
Cyp7a1 | Rat | arsane | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [APOE protein affects the susceptibility to Arsenic] which affects the expression of CYP7A1 mRNA more ... | CTD | PMID:22719926 and PMID:38945390 |
Cyp7a1 | Rat | arsenic atom | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [APOE protein affects the susceptibility to Arsenic] which affects the expression of CYP7A1 mRNA more ... | CTD | PMID:22719926 and PMID:38945390 |
Cyp7a1 | Rat | atazanavir sulfate | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA | CTD | PMID:32152650 |
Cyp7a1 | Rat | atazanavir sulfate | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Atazanavir Sulfate results in decreased expression of CYP7A1 mRNA | CTD | PMID:32152650 |
Cyp7a1 | Rat | atorvastatin calcium | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Atorvastatin results in increased expression of CYP7A1 mRNA | CTD | PMID:25278499 |
Cyp7a1 | Rat | atorvastatin calcium | multiple interactions | EXP | | 6480464 | Atorvastatin inhibits the reaction [Dietary Fats results in decreased expression of CYP7A1 mRNA] | CTD | PMID:32048413 |
Cyp7a1 | Rat | atrazine | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Atrazine results in increased expression of CYP7A1 mRNA | CTD | PMID:22515965 |
Cyp7a1 | Rat | Augmentin | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP7A1 mRNA | CTD | PMID:34767876 |
Cyp7a1 | Rat | azoxystrobin | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | azoxystrobin results in decreased expression of CYP7A1 mRNA and azoxystrobin results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | Benoxacor | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | benoxacor results in increased expression of CYP7A1 mRNA | CTD | PMID:34850242 |
Cyp7a1 | Rat | benzo[a]pyrene | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CYP7A1 mRNA | CTD | PMID:19770486 |
Cyp7a1 | Rat | benzo[a]pyrene | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of CYP7A1 mRNA | CTD | PMID:32234424 |
Cyp7a1 | Rat | benzo[a]pyrene | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [corannulene co-treated with Benzo(a)pyrene] results in increased expression of CYP7A1 mRNA | CTD | PMID:32417428 |
Cyp7a1 | Rat | benzo[a]pyrene | decreases methylation | ISO | CYP7A1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of CYP7A1 promoter | CTD | PMID:27901495 |
Cyp7a1 | Rat | benzo[a]pyrene | affects expression | EXP | | 6480464 | Benzo(a)pyrene affects the expression of CYP7A1 mRNA | CTD | PMID:22374506 |
Cyp7a1 | Rat | Benzo[b]fluorene | affects expression | EXP | | 6480464 | benzo(b)fluorene affects the expression of CYP7A1 mRNA | CTD | PMID:38903859 |
Cyp7a1 | Rat | beta-hexachlorocyclohexane | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | beta-hexachlorocyclohexane results in increased expression of CYP7A1 mRNA | CTD | PMID:28392238 |
Cyp7a1 | Rat | beta-hexachlorocyclohexane | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | beta-hexachlorocyclohexane results in increased expression of CYP7A1 mRNA | CTD | PMID:28392238 |
Cyp7a1 | Rat | beta-naphthoflavone | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of CYP7A1 mRNA | CTD | PMID:22258563 |
Cyp7a1 | Rat | bezafibrate | decreases activity | ISO | CYP7A1 (Homo sapiens) | 6480464 | Bezafibrate results in decreased activity of CYP7A1 protein | CTD | PMID:2044640 |
Cyp7a1 | Rat | bezafibrate | decreases activity | EXP | | 6480464 | Bezafibrate results in decreased activity of CYP7A1 protein | CTD | PMID:2044640 |
Cyp7a1 | Rat | bezafibrate | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Bezafibrate results in decreased expression of CYP7A1 mRNA | CTD | PMID:14685799 |
Cyp7a1 | Rat | bilirubin IXalpha | multiple interactions | EXP | | 6480464 | [Manganese co-treated with Bilirubin] results in decreased activity of CYP7A1 protein | CTD | PMID:12700418 |
Cyp7a1 | Rat | bilirubin IXalpha | decreases activity | EXP | | 6480464 | Bilirubin results in decreased activity of CYP7A1 protein | CTD | PMID:12700418 |
Cyp7a1 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of CYP7A1 mRNA | CTD | PMID:19850644 |
Cyp7a1 | Rat | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of CYP7A1 mRNA | CTD | PMID:16038268 more ... |
Cyp7a1 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [APOE gene mutant form results in increased susceptibility to Diethylhexyl Phthalate] which results in decreased expression of CYP7A1 protein more ... | CTD | PMID:19850644 more ... |
Cyp7a1 | Rat | bisphenol A | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CYP7A1 mRNA and bisphenol A results in increased expression of CYP7A1 protein | CTD | PMID:17706920 more ... |
Cyp7a1 | Rat | bisphenol A | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CYP7A1 mRNA | CTD | PMID:32156529 |
Cyp7a1 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CYP7A1 mRNA | CTD | PMID:30903817 |
Cyp7a1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CYP7A1 mRNA | CTD | PMID:25181051 more ... |
Cyp7a1 | Rat | bisphenol A | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CYP7A1 mRNA | CTD | PMID:23146750 |
Cyp7a1 | Rat | bisphenol A | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Tetrachlorodibenzodioxin co-treated with 2 more ... | CTD | PMID:17706920 more ... |
Cyp7a1 | Rat | bisphenol AF | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Dietary Fats co-treated with bisphenol AF] results in increased expression of CYP7A1 mRNA | CTD | PMID:36632902 |
Cyp7a1 | Rat | bosentan | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Bosentan results in decreased expression of CYP7A1 mRNA | CTD | PMID:29761207 |
Cyp7a1 | Rat | bromobenzene | increases expression | EXP | | 6480464 | bromobenzene results in increased expression of CYP7A1 mRNA | CTD | PMID:32479839 |
Cyp7a1 | Rat | cadmium atom | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA and Sodium Selenite inhibits the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA] | CTD | PMID:38945390 |
Cyp7a1 | Rat | cadmium atom | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP7A1 mRNA | CTD | PMID:35301059 |
Cyp7a1 | Rat | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of CYP7A1 promoter | CTD | PMID:22457795 |
Cyp7a1 | Rat | cadmium dichloride | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CYP7A1 mRNA | CTD | PMID:35301059 |
Cyp7a1 | Rat | cafestol | decreases expression | EXP | | 6480464 | cafestol results in decreased expression of CYP7A1 mRNA | CTD | PMID:9409294 |
Cyp7a1 | Rat | cafestol | decreases activity | EXP | | 6480464 | cafestol results in decreased activity of CYP7A1 protein | CTD | PMID:9409294 |
Cyp7a1 | Rat | calcipotriol | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | calcipotriene results in decreased expression of CYP7A1 protein | CTD | PMID:30419252 |
Cyp7a1 | Rat | calcipotriol | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | calcipotriene inhibits the reaction [VDR protein affects the expression of CYP7A1 protein] | CTD | PMID:30419252 |
Cyp7a1 | Rat | calcitriol | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA] more ... | CTD | PMID:19106115 and PMID:20371703 |
Cyp7a1 | Rat | calcitriol | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of CYP7A1 mRNA | CTD | PMID:20371703 |
Cyp7a1 | Rat | carbendazim | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | carbendazim results in decreased expression of CYP7A1 mRNA and carbendazim results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | carbon nanotube | affects expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Nanotubes and Carbon analog affects the expression of CYP7A1 mRNA | CTD | PMID:25620056 |
Cyp7a1 | Rat | carbon nanotube | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of CYP7A1 mRNA | CTD | PMID:25620056 |
Cyp7a1 | Rat | carnosic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | salvin inhibits the reaction [sodium arsenite results in decreased expression of CYP7A1 mRNA] | CTD | PMID:35202923 |
Cyp7a1 | Rat | carvedilol | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Carvedilol results in increased expression of CYP7A1 protein | CTD | PMID:37632784 |
Cyp7a1 | Rat | chenodeoxycholic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Chenodeoxycholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:19072826 more ... |
Cyp7a1 | Rat | chenodeoxycholic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Chenodeoxycholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:19072826 more ... |
Cyp7a1 | Rat | chenodeoxycholic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... | CTD | PMID:17963371 more ... |
Cyp7a1 | Rat | chenodeoxycholic acid | multiple interactions | EXP | | 6480464 | [Chenodeoxycholic Acid co-treated with Ketoconazole] results in decreased expression of CYP7A1 mRNA and [Chenodeoxycholic Acid results in increased expression of FGF19 protein] which results in decreased expression of CYP7A1 protein | CTD | PMID:20835427 and PMID:30985903 |
Cyp7a1 | Rat | chenodeoxycholic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP7A1 mRNA] more ... | CTD | PMID:19072826 more ... |
Cyp7a1 | Rat | chitosan | multiple interactions | EXP | | 6480464 | Chitosan inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA] and Fish Oils promotes the reaction [Chitosan inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA]] | CTD | PMID:28987369 |
Cyp7a1 | Rat | chlormequat chloride | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Chlormequat results in increased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | chloroquine | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | Chloroquine promotes the reaction [CYP7A1 protein results in increased expression of MAP1LC3B protein modified form] and CYP7A1 mRNA promotes the reaction [Chloroquine results in increased expression of MAP1LC3B protein modified form] | CTD | PMID:28275691 |
Cyp7a1 | Rat | chlorotoluron | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | chlortoluron results in decreased expression of CYP7A1 mRNA | CTD | PMID:39207506 |
Cyp7a1 | Rat | chlorpyrifos | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of CYP7A1 mRNA | CTD | PMID:32715474 |
Cyp7a1 | Rat | chlorpyrifos | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Chlorpyrifos results in decreased expression of CYP7A1 mRNA and Chlorpyrifos results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | cholate | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Cholates results in decreased expression of CYP7A1 mRNA | CTD | PMID:14684751 |
Cyp7a1 | Rat | cholate | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Cholates results in decreased expression of CYP7A1 | CTD | PMID:10809780 |
Cyp7a1 | Rat | cholesta-5,7-dien-3beta-ol | decreases activity | EXP | | 6480464 | 7-dehydrocholesterol results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | cholesterol | affects metabolic processing | ISO | CYP7A1 (Homo sapiens) | 6480464 | CYP7A1 protein affects the metabolism of Cholesterol | CTD | PMID:15696852 |
Cyp7a1 | Rat | cholesterol | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | CYP7A1 mRNA inhibits the reaction [Cholesterol results in increased phosphorylation of EIF4EBP1 protein] more ... | CTD | PMID:28275691 and PMID:30709899 |
Cyp7a1 | Rat | cholesterol | increases metabolic processing | EXP | | 6480464 | CYP7A1 protein results in increased metabolism of Cholesterol | CTD | PMID:1175606 |
Cyp7a1 | Rat | cholesterol | increases expression | EXP | | 6480464 | Cholesterol results in increased expression of CYP7A1 mRNA | CTD | PMID:21535835 |
Cyp7a1 | Rat | cholesterol | multiple interactions | EXP | | 6480464 | turmeric extract promotes the reaction [Cholesterol results in increased expression of CYP7A1 mRNA] | CTD | PMID:21535835 |
Cyp7a1 | Rat | cholesterol | increases metabolic processing | ISO | CYP7A1 (Homo sapiens) | 6480464 | CYP7A1 protein results in increased metabolism of Cholesterol | CTD | PMID:11013305 and PMID:7925343 |
Cyp7a1 | Rat | cholic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Cholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:25055961 |
Cyp7a1 | Rat | cholic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Cholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:12072388 more ... |
Cyp7a1 | Rat | cholic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Cholic Acid binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA | CTD | PMID:22540009 |
Cyp7a1 | Rat | cholic acid | multiple interactions | EXP | | 6480464 | [Cholesterol more ... | CTD | PMID:14684380 |
Cyp7a1 | Rat | chrysophanol | increases expression | EXP | | 6480464 | chrysophanic acid results in increased expression of CYP7A1 mRNA and chrysophanic acid results in increased expression of CYP7A1 protein | CTD | PMID:28161596 |
Cyp7a1 | Rat | ciguatoxin CTX1B | affects expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of CYP7A1 mRNA | CTD | PMID:18353800 |
Cyp7a1 | Rat | clavulanic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Clavulanic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:34767876 |
Cyp7a1 | Rat | clofibrate | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of CYP7A1 mRNA | CTD | PMID:17585979 |
Cyp7a1 | Rat | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CYP7A1 mRNA | CTD | PMID:19224547 |
Cyp7a1 | Rat | clofibrate | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Clofibrate results in increased expression of CYP7A1 mRNA | CTD | PMID:28973556 |
Cyp7a1 | Rat | clothianidin | decreases expression | EXP | | 6480464 | clothianidin results in decreased expression of CYP7A1 mRNA | CTD | PMID:33426623 |
Cyp7a1 | Rat | clothianidin | multiple interactions | EXP | | 6480464 | [enilconazole co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA and [thiacloprid co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA | CTD | PMID:33426623 |
Cyp7a1 | Rat | cobalt atom | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Cobalt results in increased expression of CYP7A1 mRNA | CTD | PMID:22147119 |
Cyp7a1 | Rat | copper atom | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Copper results in decreased expression of CYP7A1 mRNA | CTD | PMID:17205981 |
Cyp7a1 | Rat | copper atom | decreases activity | EXP | | 6480464 | Copper results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of CYP7A1 mRNA | CTD | PMID:11110846 |
Cyp7a1 | Rat | copper(0) | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Copper results in decreased expression of CYP7A1 mRNA | CTD | PMID:17205981 |
Cyp7a1 | Rat | copper(0) | decreases activity | EXP | | 6480464 | Copper results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of CYP7A1 mRNA | CTD | PMID:11110846 |
Cyp7a1 | Rat | copper(II) sulfate | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CYP7A1 mRNA | CTD | PMID:19549813 |
Cyp7a1 | Rat | cordycepin | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | cordycepin results in increased expression of CYP7A1 mRNA | CTD | PMID:24286368 |
Cyp7a1 | Rat | corn oil | affects expression | EXP | | 6480464 | Corn Oil affects the expression of CYP7A1 mRNA | CTD | PMID:16360708 |
Cyp7a1 | Rat | coumarin | decreases expression | EXP | | 6480464 | coumarin results in decreased expression of CYP7A1 mRNA | CTD | PMID:18480146 |
Cyp7a1 | Rat | cyclosporin A | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CYP7A1 mRNA and Cyclosporine results in decreased expression of CYP7A1 protein | CTD | PMID:20106945 more ... |
Cyp7a1 | Rat | cyclosporin A | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA and [Cyclosporine results in decreased expression of CYP7A1 protein] which affects the abundance of Cholic Acids | CTD | PMID:26198044 and PMID:32152650 |
Cyp7a1 | Rat | cyclosporin A | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of CYP7A1 mRNA | CTD | PMID:19770486 |
Cyp7a1 | Rat | cyproconazole | multiple interactions | EXP | | 6480464 | [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA | CTD | PMID:29038839 |
Cyp7a1 | Rat | cyproconazole | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | cyproconazole results in decreased expression of CYP7A1 mRNA | CTD | PMID:29995386 and PMID:39207506 |
Cyp7a1 | Rat | cyprodinil | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | cyprodinil results in decreased expression of CYP7A1 mRNA and cyprodinil results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | cysteamine | increases activity | EXP | | 6480464 | Cysteamine results in increased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | DDE | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of CYP7A1 mRNA | CTD | PMID:28392238 |
Cyp7a1 | Rat | DDE | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of CYP7A1 mRNA | CTD | PMID:28392238 |
Cyp7a1 | Rat | deoxycholic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Deoxycholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:14684751 and PMID:25055961 |
Cyp7a1 | Rat | deoxycholic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 |
Cyp7a1 | Rat | deoxycholic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Deoxycholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:20671298 more ... |
Cyp7a1 | Rat | deoxycholic acid | decreases activity | EXP | | 6480464 | Deoxycholic Acid results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | deoxycholic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Deoxycholic Acid results in increased activity of NR1H4 protein] which results in increased expression of CYP7A1 mRNA and SLCO1A1 protein affects the susceptibility to [Deoxycholic Acid results in decreased expression of CYP7A1 mRNA] | CTD | PMID:21914718 and PMID:22531947 |
Cyp7a1 | Rat | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CYP7A1 mRNA | CTD | PMID:15965953 and PMID:32599024 |
Cyp7a1 | Rat | dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of CYP7A1 mRNA | CTD | PMID:20888898 |
Cyp7a1 | Rat | dextran sulfate | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Dextran Sulfate results in decreased expression of CYP7A1 mRNA | CTD | PMID:27580383 |
Cyp7a1 | Rat | diallyl trisulfide | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | diallyl trisulfide results in decreased expression of CYP7A1 mRNA | CTD | PMID:16382202 |
Cyp7a1 | Rat | dichloroacetic acid | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of CYP7A1 mRNA | CTD | PMID:28962523 and PMID:34850242 |
Cyp7a1 | Rat | diclofenac | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Diclofenac results in increased expression of CYP7A1 mRNA and Diclofenac results in increased expression of CYP7A1 protein | CTD | PMID:26934552 and PMID:38815664 |
Cyp7a1 | Rat | diclofenac | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA and Sodium Selenite inhibits the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA] | CTD | PMID:38945390 |
Cyp7a1 | Rat | dicrotophos | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of CYP7A1 mRNA | CTD | PMID:28302478 |
Cyp7a1 | Rat | difenoconazole | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | difenoconazole results in decreased expression of CYP7A1 mRNA and difenoconazole results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | dihydroartemisinin | multiple interactions | EXP | | 15036816 | Dihydroartemisinin inhibits the reaction [ethanol increases expression of Cyp7a1 protein in liver] | RGD | |
Cyp7a1 | Rat | dihydroxyacetone | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Dihydroxyacetone results in decreased expression of CYP7A1 mRNA | CTD | PMID:32506039 |
Cyp7a1 | Rat | Diisodecyl phthalate | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | diisodecyl phthalate results in increased expression of CYP7A1 mRNA | CTD | PMID:25270620 |
Cyp7a1 | Rat | dimethomorph | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | dimethomorph results in decreased expression of CYP7A1 mRNA and dimethomorph results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | dimethyl sulfoxide | increases expression | EXP | | 15092090 | DMSO increases expression of Cyp7a1 mRNA in rat liver and reaction inhibited by INT-767 | RGD | |
Cyp7a1 | Rat | Diosbulbin B | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | diosbulbin B results in decreased expression of CYP7A1 mRNA | CTD | PMID:32148032 and PMID:39368342 |
Cyp7a1 | Rat | Diosbulbin B | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | diosbulbin B results in increased expression of CYP7A1 mRNA | CTD | PMID:39368342 |
Cyp7a1 | Rat | Diosbulbin B | decreases activity | ISO | Cyp7a1 (Mus musculus) | 6480464 | diosbulbin B results in decreased activity of CYP7A1 protein | CTD | PMID:32148032 |
Cyp7a1 | Rat | diosgenin | multiple interactions | EXP | | 6480464 | [Ethinyl Estradiol co-treated with Diosgenin] results in increased expression of CYP7A1 mRNA more ... | CTD | PMID:12963437 and PMID:33383043 |
Cyp7a1 | Rat | dioxygen | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of CYP7A1 mRNA | CTD | PMID:19695866 |
Cyp7a1 | Rat | disodium selenite | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] and Sodium Selenite inhibits the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA] | CTD | PMID:36464106 and PMID:38945390 |
Cyp7a1 | Rat | elemental selenium | multiple interactions | EXP | | 6480464 | [Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA | CTD | PMID:30031400 |
Cyp7a1 | Rat | elemental selenium | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] | CTD | PMID:36464106 |
Cyp7a1 | Rat | emodin | decreases expression | EXP | | 6480464 | Emodin results in decreased expression of CYP7A1 mRNA and Emodin results in decreased expression of CYP7A1 protein | CTD | PMID:28161596 |
Cyp7a1 | Rat | emodin | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:35753641 |
Cyp7a1 | Rat | endosulfan | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CYP7A1 mRNA | CTD | PMID:26159488 |
Cyp7a1 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of CYP7A1 mRNA | CTD | PMID:29391264 |
Cyp7a1 | Rat | endosulfan | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Endosulfan results in decreased expression of CYP7A1 mRNA | CTD | PMID:26159488 |
Cyp7a1 | Rat | enilconazole | multiple interactions | EXP | | 6480464 | [enilconazole co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA and [thiacloprid co-treated with enilconazole] results in decreased expression of CYP7A1 mRNA | CTD | PMID:33426623 |
Cyp7a1 | Rat | enilconazole | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | enilconazole results in decreased expression of CYP7A1 mRNA and enilconazole results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 and PMID:32201337 |
Cyp7a1 | Rat | enilconazole | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | enilconazole results in decreased expression of CYP7A1 mRNA | CTD | PMID:29451352 and PMID:32814239 |
Cyp7a1 | Rat | Epomediol | increases activity | EXP | | 6480464 | epomediol results in increased activity of CYP7A1 protein | CTD | PMID:10961725 and PMID:11473529 |
Cyp7a1 | Rat | Epomediol | increases expression | EXP | | 6480464 | epomediol results in increased expression of CYP7A1 mRNA | CTD | PMID:11473529 |
Cyp7a1 | Rat | epoxiconazole | multiple interactions | EXP | | 6480464 | [cyproconazole co-treated with epoxiconazole] results in increased expression of CYP7A1 mRNA | CTD | PMID:29038839 |
Cyp7a1 | Rat | epoxiconazole | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of CYP7A1 mRNA | CTD | PMID:35436446 |
Cyp7a1 | Rat | epoxiconazole | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | epoxiconazole results in decreased expression of CYP7A1 mRNA | CTD | PMID:32194361 |
Cyp7a1 | Rat | ethambutol | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein | CTD | PMID:35835356 |
Cyp7a1 | Rat | ethambutol | multiple interactions | EXP | | 6480464 | [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein | CTD | PMID:35835356 |
Cyp7a1 | Rat | ethanol | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:17347304 and PMID:35872049 |
Cyp7a1 | Rat | ethanol | increases expression | EXP | | 15036816 | ethanol increases expression of Cyp7a1 protein in liver | RGD | |
Cyp7a1 | Rat | ethanol | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Ethanol results in increased expression of CYP7A1 mRNA and Ethanol results in increased expression of CYP7A1 protein | CTD | PMID:19167417 more ... |
Cyp7a1 | Rat | ethanol | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | AM 251 inhibits the reaction [Ethanol results in increased expression of CYP7A1 mRNA] more ... | CTD | PMID:23894352 and PMID:28095641 |
Cyp7a1 | Rat | ethoprophos | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | ethoprop results in decreased expression of CYP7A1 mRNA and ethoprop results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | fenbuconazole | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | fenbuconazole results in decreased expression of CYP7A1 mRNA | CTD | PMID:15942997 |
Cyp7a1 | Rat | fenhexamid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | N-(2 and 3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in decreased expression of CYP7A1 mRNA | CTD | PMID:32194361 |
Cyp7a1 | Rat | fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA | CTD | PMID:18253720 |
Cyp7a1 | Rat | fenofibrate | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Fenofibrate results in decreased expression of CYP7A1 mRNA | CTD | PMID:14685799 |
Cyp7a1 | Rat | fenpyroximate | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | fenpyroximate results in decreased expression of CYP7A1 mRNA and fenpyroximate results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | fenvalerate | decreases expression | EXP | | 6480464 | fenvalerate results in decreased expression of CYP7A1 mRNA | CTD | PMID:30307764 |
Cyp7a1 | Rat | Fexaramine | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | fexaramine inhibits the reaction [Aflatoxin B1 results in increased expression of CYP7A1 mRNA] | CTD | PMID:37030333 |
Cyp7a1 | Rat | fipronil | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | fipronil results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | fipronil | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | fipronil results in increased expression of CYP7A1 mRNA | CTD | PMID:32194361 |
Cyp7a1 | Rat | fisetin | multiple interactions | EXP | | 6480464 | fisetin inhibits the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA] | CTD | PMID:23524313 |
Cyp7a1 | Rat | flavonoids | increases expression | EXP | | 6480464 | Flavonoids results in increased expression of CYP7A1 mRNA | CTD | PMID:18035473 |
Cyp7a1 | Rat | fludioxonil | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | fludioxonil results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | flumequine | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA and Sodium Selenite inhibits the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA] | CTD | PMID:38945390 |
Cyp7a1 | Rat | flusilazole | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | flusilazole results in decreased expression of CYP7A1 mRNA | CTD | PMID:32194361 |
Cyp7a1 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of CYP7A1 mRNA | CTD | PMID:24136188 |
Cyp7a1 | Rat | fluxapyroxad | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | fluxapyroxad results in decreased expression of CYP7A1 mRNA and fluxapyroxad results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | furan | decreases expression | EXP | | 6480464 | furan results in decreased expression of CYP7A1 mRNA | CTD | PMID:15120968 and PMID:38160780 |
Cyp7a1 | Rat | furan | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | furan results in decreased expression of CYP7A1 mRNA | CTD | PMID:32251705 |
Cyp7a1 | Rat | furan | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | rhodioloside inhibits the reaction [furan results in decreased expression of CYP7A1 mRNA] | CTD | PMID:32251705 |
Cyp7a1 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of CYP7A1 mRNA | CTD | PMID:25539665 |
Cyp7a1 | Rat | gemfibrozil | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Gemfibrozil results in decreased expression of CYP7A1 mRNA | CTD | PMID:14685799 |
Cyp7a1 | Rat | genistein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in decreased expression of CYP7A1 mRNA | CTD | PMID:21782745 |
Cyp7a1 | Rat | Gentiopicrin | decreases expression | EXP | | 15045612 | Gentiopicrin decreases expression of Cyp7a1 mRNA in rat ANIT induced cholestatic liver | RGD | |
Cyp7a1 | Rat | glycochenodeoxycholic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 |
Cyp7a1 | Rat | glycocholic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 |
Cyp7a1 | Rat | glycodeoxycholic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Atazanavir Sulfate co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA more ... | CTD | PMID:32152650 and PMID:33819548 |
Cyp7a1 | Rat | glycyrrhetinate | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] | CTD | PMID:28549656 |
Cyp7a1 | Rat | glycyrrhetinic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] | CTD | PMID:28549656 |
Cyp7a1 | Rat | glycyrrhizinic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | Glycyrrhizic Acid inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] | CTD | PMID:28549656 |
Cyp7a1 | Rat | glycyrrhizinic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Glycyrrhizic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:22982774 |
Cyp7a1 | Rat | gold atom | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Gold analog results in increased expression of CYP7A1 mRNA | CTD | PMID:36057382 |
Cyp7a1 | Rat | gold(0) | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Gold analog results in increased expression of CYP7A1 mRNA | CTD | PMID:36057382 |
Cyp7a1 | Rat | graphene oxide | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | graphene oxide results in increased expression of CYP7A1 mRNA | CTD | PMID:33227293 |
Cyp7a1 | Rat | guggulsterone | multiple interactions | EXP | | 15036816 | Z-guggulsterone reverses the reaction [Dihydroartemisinin inhibits the reaction [ethanol increases expression of Cyp7a1 protein in liver]] | RGD | |
Cyp7a1 | Rat | guggulsterone | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | pregna-4 more ... | CTD | PMID:25655198 more ... |
Cyp7a1 | Rat | guggulsterone | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | pregna-4 more ... | CTD | PMID:12705905 and PMID:35523117 |
Cyp7a1 | Rat | GW 3965 | increases expression | EXP | | 6480464 | GW 3965 results in increased expression of CYP7A1 mRNA | CTD | PMID:17420776 |
Cyp7a1 | Rat | GW 4064 | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | GW 4064 results in decreased expression of CYP7A1 mRNA | CTD | PMID:31437187 |
Cyp7a1 | Rat | GW 4064 | decreases expression | EXP | | 6480464 | GW 4064 results in decreased expression of CYP7A1 mRNA | CTD | PMID:14623915 and PMID:15644430 |
Cyp7a1 | Rat | GW 4064 | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | GW 4064 results in decreased expression of CYP7A1 mRNA | CTD | PMID:27609522 and PMID:36511616 |
Cyp7a1 | Rat | GW 4064 | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [GW 4064 binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA more ... | CTD | PMID:22467244 more ... |
Cyp7a1 | Rat | GW 7647 | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | GW 7647 results in decreased expression of CYP7A1 mRNA | CTD | PMID:38117326 |
Cyp7a1 | Rat | Heliotrine | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | heliotrine results in decreased expression of CYP7A1 mRNA | CTD | PMID:26100227 |
Cyp7a1 | Rat | hexadecanoic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP7A1 mRNA and Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP7A1 mRNA] | CTD | PMID:38103844 |
Cyp7a1 | Rat | hyperforin | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | hyperforin results in decreased expression of CYP7A1 mRNA | CTD | PMID:24259679 |
Cyp7a1 | Rat | ibuprofen | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Ibuprofen results in increased expression of CYP7A1 mRNA and Ibuprofen results in increased expression of CYP7A1 protein | CTD | PMID:38815664 |
Cyp7a1 | Rat | icariside II | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | baohuoside I results in increased expression of CYP7A1 mRNA and baohuoside I results in increased expression of CYP7A1 protein | CTD | PMID:35802278 |
Cyp7a1 | Rat | icariside II | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | baohuoside I results in increased expression of CYP7A1 mRNA and baohuoside I results in increased expression of CYP7A1 protein | CTD | PMID:35802278 |
Cyp7a1 | Rat | imipenem hydrate | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Vancomycin co-treated with Imipenem] results in decreased expression of CYP7A1 mRNA | CTD | PMID:24657338 |
Cyp7a1 | Rat | indometacin | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Indomethacin results in increased expression of CYP7A1 mRNA and Indomethacin results in increased expression of CYP7A1 protein | CTD | PMID:38815664 |
Cyp7a1 | Rat | indoxyl sulfate | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Indican results in decreased expression of CYP7A1 mRNA | CTD | PMID:30639138 |
Cyp7a1 | Rat | iprodione | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | iprodione results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | isoniazide | multiple interactions | EXP | | 6480464 | [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein more ... | CTD | PMID:25331106 more ... |
Cyp7a1 | Rat | isoniazide | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein and [Isoniazid co-treated with Vitamin B 6] results in increased expression of CYP7A1 mRNA | CTD | PMID:32673658 and PMID:35835356 |
Cyp7a1 | Rat | isoniazide | increases expression | EXP | | 6480464 | Isoniazid results in increased expression of CYP7A1 mRNA | CTD | PMID:25331106 and PMID:32673658 |
Cyp7a1 | Rat | kaempferol | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | kaempferol analog inhibits the reaction [Acetaminophen results in increased expression of CYP7A1 mRNA] | CTD | PMID:36150480 |
Cyp7a1 | Rat | ketoconazole | multiple interactions | EXP | | 6480464 | [Chenodeoxycholic Acid co-treated with Ketoconazole] results in decreased expression of CYP7A1 mRNA | CTD | PMID:30985903 |
Cyp7a1 | Rat | ketoconazole | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Ketoconazole results in increased expression of CYP7A1 mRNA | CTD | PMID:31099283 |
Cyp7a1 | Rat | kojic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA and [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP7A1 mRNA | CTD | PMID:17917374 |
Cyp7a1 | Rat | L-1,4-dithiothreitol | increases activity | EXP | | 6480464 | Dithiothreitol results in increased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | L-ascorbic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA and [Diethylnitrosamine co-treated with kojic acid co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA | CTD | PMID:17917374 |
Cyp7a1 | Rat | Lasiocarpine | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | lasiocarpine results in decreased expression of CYP7A1 mRNA | CTD | PMID:32234424 |
Cyp7a1 | Rat | lead nitrate | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | lead nitrate results in decreased expression of CYP7A1 mRNA | CTD | PMID:16049268 and PMID:22293356 |
Cyp7a1 | Rat | lead nitrate | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [IL1A gene mutant form co-treated with IL1B gene mutant form] inhibits the reaction [lead nitrate results in decreased expression of CYP7A1 mRNA] | CTD | PMID:22293356 |
Cyp7a1 | Rat | lead nitrate | decreases expression | EXP | | 6480464 | lead nitrate results in decreased expression of CYP7A1 mRNA | CTD | PMID:15475176 |
Cyp7a1 | Rat | lead(0) | multiple interactions | EXP | | 6480464 | puerarin affects the reaction [Lead affects the expression of CYP7A1] | CTD | PMID:22001170 |
Cyp7a1 | Rat | lead(0) | decreases activity | EXP | | 6480464 | Lead results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of CYP7A1 | CTD | PMID:22001170 |
Cyp7a1 | Rat | lipopolysaccharide | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:22777745 and PMID:35811015 |
Cyp7a1 | Rat | lipopolysaccharide | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [triptolide co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 protein and obeticholic acid inhibits the reaction [[triptolide co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 protein] | CTD | PMID:36328986 |
Cyp7a1 | Rat | lipopolysaccharide | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of CYP7A1 mRNA | CTD | PMID:35811015 |
Cyp7a1 | Rat | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [Lipopolysaccharides co-treated with Isoniazid] results in increased expression of CYP7A1 mRNA | CTD | PMID:25331106 |
Cyp7a1 | Rat | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of CYP7A1 mRNA | CTD | PMID:25331106 |
Cyp7a1 | Rat | lithocholic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Lithocholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:25055961 |
Cyp7a1 | Rat | lithocholic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Lithocholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:16436656 more ... |
Cyp7a1 | Rat | lithocholic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Lithocholic Acid analog binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA and [Lithocholic Acid binds to and results in increased activity of NR1H4 protein] which results in decreased expression of CYP7A1 mRNA | CTD | PMID:17963371 |
Cyp7a1 | Rat | lithocholic acid | decreases activity | EXP | | 6480464 | Lithocholic Acid results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | lithocholic acid | decreases expression | EXP | | 6480464 | Lithocholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:20888898 |
Cyp7a1 | Rat | lithocholic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:19196849 more ... |
Cyp7a1 | Rat | loperamide | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Loperamide results in increased expression of CYP7A1 mRNA | CTD | PMID:35926757 |
Cyp7a1 | Rat | magnesium atom | multiple interactions | EXP | | 6480464 | [Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA | CTD | PMID:30031400 |
Cyp7a1 | Rat | maneb | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Maneb results in decreased expression of CYP7A1 mRNA | CTD | PMID:32194361 |
Cyp7a1 | Rat | manganese atom | multiple interactions | EXP | | 6480464 | [Manganese co-treated with Bilirubin] results in decreased activity of CYP7A1 protein | CTD | PMID:12700418 |
Cyp7a1 | Rat | manganese atom | increases activity | EXP | | 6480464 | Manganese results in increased activity of CYP7A1 protein | CTD | PMID:12700418 |
Cyp7a1 | Rat | manganese(0) | multiple interactions | EXP | | 6480464 | [Manganese co-treated with Bilirubin] results in decreased activity of CYP7A1 protein | CTD | PMID:12700418 |
Cyp7a1 | Rat | manganese(0) | increases activity | EXP | | 6480464 | Manganese results in increased activity of CYP7A1 protein | CTD | PMID:12700418 |
Cyp7a1 | Rat | melatonin | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | Melatonin inhibits the reaction [Ethanol results in increased expression of CYP7A1 mRNA] more ... | CTD | PMID:28095641 |
Cyp7a1 | Rat | melatonin | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Melatonin results in decreased expression of CYP7A1 mRNA | CTD | PMID:28095641 |
Cyp7a1 | Rat | mercaptoethanol | increases activity | EXP | | 6480464 | Mercaptoethanol results in increased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | mercury atom | decreases activity | EXP | | 6480464 | Mercury results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | mercury atom | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA and Sodium Selenite inhibits the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA] | CTD | PMID:38945390 |
Cyp7a1 | Rat | mercury(0) | decreases activity | EXP | | 6480464 | Mercury results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | mercury(0) | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA and Sodium Selenite inhibits the reaction [[Cadmium co-treated with Arsenic co-treated with Mercury co-treated with Diclofenac co-treated with flumequine] results in decreased expression of CYP7A1 mRNA] | CTD | PMID:38945390 |
Cyp7a1 | Rat | metacetamol | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | 3-hydroxyacetanilide results in decreased expression of CYP7A1 mRNA | CTD | PMID:18544908 |
Cyp7a1 | Rat | metalaxyl | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | metalaxyl results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | metformin | multiple interactions | EXP | | 6480464 | Metformin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 mRNA] and Metformin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 protein] | CTD | PMID:31100278 |
Cyp7a1 | Rat | metformin | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Metformin results in increased expression of CYP7A1 protein | CTD | PMID:34058177 |
Cyp7a1 | Rat | metformin | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Ethinyl Estradiol co-treated with Metformin] results in decreased expression of CYP7A1 mRNA and [Metformin co-treated with Ethinyl Estradiol] results in decreased expression of CYP7A1 protein | CTD | PMID:34058177 |
Cyp7a1 | Rat | metformin | affects expression | EXP | | 6480464 | Metformin affects the expression of CYP7A1 mRNA | CTD | PMID:31324951 |
Cyp7a1 | Rat | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of CYP7A1 mRNA | CTD | PMID:30467583 |
Cyp7a1 | Rat | methotrexate | decreases expression | EXP | | 6480464 | Methotrexate results in decreased expression of CYP7A1 mRNA | CTD | PMID:15120968 |
Cyp7a1 | Rat | methotrexate | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of CYP7A1 mRNA | CTD | PMID:24449571 |
Cyp7a1 | Rat | methoxsalen | decreases expression | EXP | | 6480464 | Methoxsalen results in decreased expression of CYP7A1 mRNA | CTD | PMID:28552422 |
Cyp7a1 | Rat | methoxsalen | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Methoxsalen results in decreased expression of CYP7A1 protein | CTD | PMID:30419252 |
Cyp7a1 | Rat | methoxsalen | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | Methoxsalen affects the reaction [VDR protein affects the expression of CYP7A1 protein] | CTD | PMID:30419252 |
Cyp7a1 | Rat | methoxsalen | increases expression | EXP | | 6480464 | Methoxsalen results in increased expression of CYP7A1 protein | CTD | PMID:28552422 |
Cyp7a1 | Rat | methoxychlor | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in decreased expression of CYP7A1 mRNA | CTD | PMID:21782745 |
Cyp7a1 | Rat | metronidazole | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] more ... | CTD | PMID:36464106 and PMID:37211107 |
Cyp7a1 | Rat | monocrotaline | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA | CTD | PMID:21224054 |
Cyp7a1 | Rat | monocrotophos | increases expression | EXP | | 6480464 | Monocrotophos results in increased expression of CYP7A1 mRNA | CTD | PMID:32267039 |
Cyp7a1 | Rat | monosodium L-glutamate | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Sodium Glutamate co-treated with High Fructose Corn Syrup] results in increased expression of CYP7A1 mRNA | CTD | PMID:20111022 |
Cyp7a1 | Rat | monosodium L-glutamate | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Sodium Glutamate results in increased expression of CYP7A1 mRNA | CTD | PMID:19001666 and PMID:20111022 |
Cyp7a1 | Rat | Muraglitazar | increases expression | EXP | | 6480464 | muraglitazar results in increased expression of CYP7A1 mRNA | CTD | PMID:21515302 |
Cyp7a1 | Rat | N-nitrosodiethylamine | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Ascorbic Acid] results in increased expression of CYP7A1 mRNA more ... | CTD | PMID:17917374 more ... |
Cyp7a1 | Rat | N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CYP7A1 mRNA | CTD | PMID:19638242 |
Cyp7a1 | Rat | N-nitrosodiethylamine | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of CYP7A1 mRNA | CTD | PMID:18691550 |
Cyp7a1 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in decreased expression of CYP7A1 mRNA more ... | CTD | PMID:14656948 more ... |
Cyp7a1 | Rat | N-Nitrosopyrrolidine | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of CYP7A1 mRNA | CTD | PMID:32234424 |
Cyp7a1 | Rat | nefazodone | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of CYP7A1 mRNA | CTD | PMID:32152650 |
Cyp7a1 | Rat | nefazodone | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | nefazodone results in decreased expression of CYP7A1 mRNA | CTD | PMID:32152650 |
Cyp7a1 | Rat | neomycin | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] more ... | CTD | PMID:36464106 and PMID:37211107 |
Cyp7a1 | Rat | nickel atom | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Nickel results in increased expression of CYP7A1 mRNA | CTD | PMID:18922574 |
Cyp7a1 | Rat | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of CYP7A1 mRNA | CTD | PMID:33484710 |
Cyp7a1 | Rat | O-methyleugenol | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of CYP7A1 mRNA | CTD | PMID:32234424 |
Cyp7a1 | Rat | obeticholic acid | decreases expression | EXP | | 15045602 | obeticholic acid decreases expression of CYP7a1 mRNA in liver in porcine serum induced model of cirrhosis in rat | RGD | |
Cyp7a1 | Rat | obeticholic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | obeticholic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein] more ... | CTD | PMID:29660435 more ... |
Cyp7a1 | Rat | obeticholic acid | multiple interactions | EXP | | 6480464 | obeticholic acid inhibits the reaction [Isoniazid results in increased expression of CYP7A1 mRNA] | CTD | PMID:32673658 |
Cyp7a1 | Rat | obeticholic acid | decreases expression | EXP | | 6480464 | obeticholic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:15644430 and PMID:35267068 |
Cyp7a1 | Rat | obeticholic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | obeticholic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:15911693 and PMID:27939613 |
Cyp7a1 | Rat | obeticholic acid | multiple interactions | EXP | | 15036816 | Obeticholic acid inhibits the reaction [ethanol increases expression of Cyp7a1 protein in liver] | RGD | |
Cyp7a1 | Rat | okadaic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | Okadaic Acid promotes the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA] and Okadaic Acid promotes the reaction [lithocholic acid acetate results in decreased expression of CYP7A1 mRNA] | CTD | PMID:20371703 |
Cyp7a1 | Rat | okadaic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:38832940 |
Cyp7a1 | Rat | oleanolic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Oleanolic Acid results in decreased expression of CYP7A1 mRNA and Oleanolic Acid results in decreased expression of CYP7A1 protein | CTD | PMID:23948738 and PMID:37028458 |
Cyp7a1 | Rat | oleanolic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | GW 4064 inhibits the reaction [Oleanolic Acid results in decreased expression of CYP7A1 mRNA] more ... | CTD | PMID:37028458 |
Cyp7a1 | Rat | oleic acid | decreases expression | EXP | | 6480464 | Oleic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:32738331 |
Cyp7a1 | Rat | oleic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP7A1 mRNA and Coptidis rhizoma extract inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of CYP7A1 mRNA] | CTD | PMID:38103844 |
Cyp7a1 | Rat | orphenadrine | affects expression | EXP | | 6480464 | Orphenadrine affects the expression of CYP7A1 mRNA | CTD | PMID:23665939 |
Cyp7a1 | Rat | oxybenzone | increases expression | EXP | | 6480464 | oxybenzone results in increased expression of CYP7A1 mRNA | CTD | PMID:30316929 |
Cyp7a1 | Rat | p-chloromercuribenzoic acid | decreases activity | EXP | | 6480464 | p-Chloromercuribenzoic Acid results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | paclitaxel | decreases expression | EXP | | 6480464 | Paclitaxel results in decreased expression of CYP7A1 mRNA | CTD | PMID:15585946 |
Cyp7a1 | Rat | paracetamol | affects expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of CYP7A1 mRNA | CTD | PMID:15030884 and PMID:17562736 |
Cyp7a1 | Rat | paracetamol | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CYP7A1 mRNA | CTD | PMID:36150480 |
Cyp7a1 | Rat | paracetamol | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP7A1 mRNA and kaempferol analog inhibits the reaction [Acetaminophen results in increased expression of CYP7A1 mRNA] | CTD | PMID:33819548 and PMID:36150480 |
Cyp7a1 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CYP7A1 mRNA | CTD | PMID:15120968 and PMID:17202762 |
Cyp7a1 | Rat | paracetamol | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of CYP7A1 mRNA | CTD | PMID:18544908 |
Cyp7a1 | Rat | paraquat | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Paraquat results in decreased expression of CYP7A1 mRNA | CTD | PMID:34681664 |
Cyp7a1 | Rat | parathion | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Parathion results in increased expression of CYP7A1 mRNA | CTD | PMID:34813904 |
Cyp7a1 | Rat | pentachlorophenol | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of CYP7A1 mRNA | CTD | PMID:23892564 |
Cyp7a1 | Rat | perflubutane | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | perfluorobutane results in decreased expression of CYP7A1 mRNA | CTD | PMID:23567314 |
Cyp7a1 | Rat | perfluorobutanesulfonic acid | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | perfluorobutanesulfonic acid results in increased expression of CYP7A1 mRNA | CTD | PMID:32534104 |
Cyp7a1 | Rat | perfluorobutyric acid | increases expression | EXP | | 6480464 | perfluorobutyric acid analog results in increased expression of CYP7A1 mRNA | CTD | PMID:21878386 |
Cyp7a1 | Rat | perfluorodecanoic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluorodecanoic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:23567314 |
Cyp7a1 | Rat | perfluorodecanoic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | perfluorodecanoic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:27344344 and PMID:38181850 |
Cyp7a1 | Rat | perfluorodecanoic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | PPARA protein affects the reaction [perfluorodecanoic acid results in decreased expression of CYP7A1 mRNA] | CTD | PMID:27344344 |
Cyp7a1 | Rat | perfluorodecanoic acid | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | perfluorodecanoic acid results in increased expression of CYP7A1 mRNA | CTD | PMID:23567314 |
Cyp7a1 | Rat | perfluorododecanoic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluorododecanoic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:23567314 |
Cyp7a1 | Rat | perfluorododecanoic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | perfluorododecanoic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:23567314 |
Cyp7a1 | Rat | perfluoroheptanoic acid | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluoro-n-heptanoic acid results in increased expression of CYP7A1 mRNA | CTD | PMID:35337807 |
Cyp7a1 | Rat | perfluorohexanesulfonic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:21705711 more ... |
Cyp7a1 | Rat | perfluorohexanesulfonic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid] results in decreased expression of CYP7A1 mRNA | CTD | PMID:38117326 |
Cyp7a1 | Rat | perfluorohexanesulfonic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:23567314 |
Cyp7a1 | Rat | perfluorohexanoic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluorohexanoic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:23567314 |
Cyp7a1 | Rat | perfluorononanoic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:23567314 more ... |
Cyp7a1 | Rat | perfluorononanoic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid] results in decreased expression of CYP7A1 mRNA | CTD | PMID:38117326 |
Cyp7a1 | Rat | perfluorononanoic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:29112762 |
Cyp7a1 | Rat | perfluorononanoic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in decreased expression of CYP7A1 mRNA | CTD | PMID:33483757 |
Cyp7a1 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:16221955 more ... |
Cyp7a1 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid] results in decreased expression of CYP7A1 mRNA | CTD | PMID:38117326 |
Cyp7a1 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in increased expression of CYP7A1 mRNA | CTD | PMID:33772556 |
Cyp7a1 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA and perfluorooctane sulfonic acid results in decreased expression of CYP7A1 protein | CTD | PMID:27153767 more ... |
Cyp7a1 | Rat | perfluorooctane-1-sulfonic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:19429403 more ... |
Cyp7a1 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CYP7A1 mRNA and PPARA protein promotes the reaction [perfluorooctane sulfonic acid results in decreased expression of CYP7A1 mRNA] | CTD | PMID:20936131 and PMID:36331819 |
Cyp7a1 | Rat | perfluorooctanesulfonamide | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluorooctanesulfonamide analog results in increased expression of CYP7A1 mRNA | CTD | PMID:35337807 |
Cyp7a1 | Rat | perfluorooctanoic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | PPARA protein promotes the reaction [perfluorooctanoic acid results in decreased expression of CYP7A1 mRNA] | CTD | PMID:20936131 |
Cyp7a1 | Rat | perfluorooctanoic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid co-treated with perfluorohexanesulfonic acid] results in decreased expression of CYP7A1 mRNA | CTD | PMID:38117326 |
Cyp7a1 | Rat | perfluorooctanoic acid | affects expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | perfluorooctanoic acid affects the expression of CYP7A1 mRNA | CTD | PMID:38182912 |
Cyp7a1 | Rat | perfluorooctanoic acid | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of CYP7A1 mRNA | CTD | PMID:33772556 |
Cyp7a1 | Rat | perfluorooctanoic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of CYP7A1 mRNA and perfluorooctanoic acid results in decreased expression of CYP7A1 protein | CTD | PMID:23567314 more ... |
Cyp7a1 | Rat | perfluorooctanoic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | perfluorooctanoic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:17681415 more ... |
Cyp7a1 | Rat | perfluoropentanoic acid | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluoropentanoic acid results in increased expression of CYP7A1 mRNA | CTD | PMID:35337807 |
Cyp7a1 | Rat | perfluoroundecanoic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | perfluoroundecanoic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:23567314 |
Cyp7a1 | Rat | phenformin | decreases expression | EXP | | 6480464 | Phenformin results in decreased expression of CYP7A1 mRNA | CTD | PMID:31324951 |
Cyp7a1 | Rat | phenobarbital | affects expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of CYP7A1 mRNA | CTD | PMID:15629111 |
Cyp7a1 | Rat | phenobarbital | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Phenobarbital results in increased expression of CYP7A1 mRNA | CTD | PMID:22258563 |
Cyp7a1 | Rat | phenobarbital | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CYP7A1 mRNA | CTD | PMID:24535843 |
Cyp7a1 | Rat | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of CYP7A1 mRNA | CTD | PMID:19162173 |
Cyp7a1 | Rat | phenobarbital | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of CYP7A1 mRNA | CTD | PMID:15629111 |
Cyp7a1 | Rat | phenobarbital | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of CYP7A1 mRNA | CTD | PMID:19270015 |
Cyp7a1 | Rat | phenytoin | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA | CTD | PMID:21224054 |
Cyp7a1 | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CYP7A1 mRNA | CTD | PMID:16979875 |
Cyp7a1 | Rat | phosphatidylcholine | increases activity | EXP | | 6480464 | Phosphatidylcholines results in increased activity of CYP7A1 protein | CTD | PMID:12559476 |
Cyp7a1 | Rat | pioglitazone | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | pioglitazone promotes the reaction [U 0126 results in increased expression of CYP7A1 mRNA] and U 0126 promotes the reaction [pioglitazone results in increased expression of CYP7A1 mRNA] | CTD | PMID:22593575 |
Cyp7a1 | Rat | pioglitazone | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | pioglitazone results in increased expression of CYP7A1 mRNA | CTD | PMID:22593575 |
Cyp7a1 | Rat | pirinixic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | PPARA protein affects the reaction [pirinixic acid results in decreased expression of CYP7A1 mRNA] and PPARA protein promotes the reaction [pirinixic acid results in decreased expression of CYP7A1 mRNA] | CTD | PMID:15777286 more ... |
Cyp7a1 | Rat | pirinixic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | pirinixic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:31676336 |
Cyp7a1 | Rat | pirinixic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:15777286 more ... |
Cyp7a1 | Rat | pirinixic acid | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CYP7A1 mRNA | CTD | PMID:20936131 |
Cyp7a1 | Rat | pregnenolone | decreases activity | EXP | | 6480464 | Pregnenolone results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CYP7A1 mRNA | CTD | PMID:19162173 |
Cyp7a1 | Rat | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CYP7A1 mRNA | CTD | PMID:15629111 more ... |
Cyp7a1 | Rat | pregnenolone 16alpha-carbonitrile | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in decreased expression of CYP7A1 mRNA] | CTD | PMID:20359477 |
Cyp7a1 | Rat | prochloraz | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | prochloraz results in decreased expression of CYP7A1 mRNA | CTD | PMID:32194361 |
Cyp7a1 | Rat | procymidone | affects expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | procymidone affects the expression of CYP7A1 mRNA | CTD | PMID:36764477 |
Cyp7a1 | Rat | propiconazole | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | propiconazole results in increased expression of CYP7A1 mRNA | CTD | PMID:21278054 |
Cyp7a1 | Rat | propiconazole | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | propiconazole results in decreased expression of CYP7A1 mRNA | CTD | PMID:32194361 and PMID:36291160 |
Cyp7a1 | Rat | prothioconazole | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | prothioconazole results in increased expression of CYP7A1 mRNA | CTD | PMID:36007749 |
Cyp7a1 | Rat | Prothioconazole-desthio | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | prothioconazole-desthio results in increased expression of CYP7A1 mRNA | CTD | PMID:36007749 |
Cyp7a1 | Rat | psoralen | decreases expression | EXP | | 6480464 | Ficusin results in decreased expression of CYP7A1 mRNA and Ficusin results in decreased expression of CYP7A1 protein | CTD | PMID:30597224 |
Cyp7a1 | Rat | puerarin | multiple interactions | EXP | | 6480464 | puerarin affects the reaction [Lead affects the expression of CYP7A1] | CTD | PMID:22001170 |
Cyp7a1 | Rat | PX-866 | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [PX-866 co-treated with SORT1 protein] results in decreased expression of CYP7A1 mRNA | CTD | PMID:25805502 |
Cyp7a1 | Rat | pyrazinecarboxamide | increases expression | EXP | | 6480464 | Pyrazinamide results in increased expression of CYP7A1 mRNA and Pyrazinamide results in increased expression of CYP7A1 protein | CTD | PMID:27255380 |
Cyp7a1 | Rat | pyrazinecarboxamide | multiple interactions | EXP | | 6480464 | [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein | CTD | PMID:35835356 |
Cyp7a1 | Rat | pyrazinecarboxamide | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein | CTD | PMID:35835356 |
Cyp7a1 | Rat | pyrrolidines | decreases expression | EXP | | 6480464 | Pyrrolidines analog results in decreased expression of CYP7A1 mRNA | CTD | PMID:26365562 |
Cyp7a1 | Rat | resveratrol | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Resveratrol results in increased activity of NR1H3 protein] which results in increased expression of CYP7A1 mRNA more ... | CTD | PMID:22607622 and PMID:31298478 |
Cyp7a1 | Rat | resveratrol | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | resveratrol results in increased expression of CYP7A1 mRNA | CTD | PMID:22607622 and PMID:23146569 |
Cyp7a1 | Rat | resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA] and resveratrol inhibits the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 protein] | CTD | PMID:25418378 |
Cyp7a1 | Rat | rifampicin | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of CYP7A1 mRNA | CTD | PMID:21224054 |
Cyp7a1 | Rat | rifampicin | multiple interactions | EXP | | 6480464 | [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of CYP7A1 protein | CTD | PMID:35835356 |
Cyp7a1 | Rat | rifampicin | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in increased expression of CYP7A1 protein and NR1I2 protein promotes the reaction [Rifampin results in decreased expression of CYP7A1 mRNA] | CTD | PMID:21127053 and PMID:35835356 |
Cyp7a1 | Rat | rifampicin | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Rifampin results in decreased expression of CYP7A1 mRNA | CTD | PMID:15629111 more ... |
Cyp7a1 | Rat | rifaximin | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of CYP7A1 protein | CTD | PMID:22790967 |
Cyp7a1 | Rat | ritonavir | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Ritonavir results in decreased expression of CYP7A1 mRNA | CTD | PMID:26626330 |
Cyp7a1 | Rat | ritonavir | decreases expression | EXP | | 6480464 | Ritonavir results in decreased expression of CYP7A1 mRNA | CTD | PMID:17719200 |
Cyp7a1 | Rat | rotenone | affects expression | EXP | | 6480464 | Rotenone affects the expression of CYP7A1 mRNA | CTD | PMID:28374803 |
Cyp7a1 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 |
Cyp7a1 | Rat | Salidroside | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | rhodioloside inhibits the reaction [furan results in decreased expression of CYP7A1 mRNA] | CTD | PMID:32251705 |
Cyp7a1 | Rat | saracatinib | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | saracatinib results in increased expression of CYP7A1 mRNA | CTD | PMID:20371703 |
Cyp7a1 | Rat | saracatinib | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | saracatinib inhibits the reaction [Calcitriol results in decreased expression of CYP7A1 mRNA] more ... | CTD | PMID:20371703 |
Cyp7a1 | Rat | selenium atom | multiple interactions | EXP | | 6480464 | [Magnesium co-treated with Selenium co-treated with Dietary Fats] results in increased expression of CYP7A1 mRNA | CTD | PMID:30031400 |
Cyp7a1 | Rat | selenium atom | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] | CTD | PMID:36464106 |
Cyp7a1 | Rat | senecionine | decreases expression | EXP | | 6480464 | senecionine results in decreased expression of CYP7A1 mRNA | CTD | PMID:24641316 |
Cyp7a1 | Rat | senecionine | affects expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | senecionine affects the expression of CYP7A1 mRNA | CTD | PMID:38703205 |
Cyp7a1 | Rat | senecionine | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | senecionine results in increased expression of CYP7A1 mRNA | CTD | PMID:38703205 |
Cyp7a1 | Rat | senecionine | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | obeticholic acid inhibits the reaction [senecionine results in decreased expression of CYP7A1 mRNA] | CTD | PMID:38703205 |
Cyp7a1 | Rat | senecionine | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | senecionine results in decreased expression of CYP7A1 mRNA | CTD | PMID:31606820 |
Cyp7a1 | Rat | senecionine | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | senecionine results in decreased expression of CYP7A1 mRNA | CTD | PMID:26100227 |
Cyp7a1 | Rat | Senkirkine | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | senkirkine results in decreased expression of CYP7A1 mRNA | CTD | PMID:26100227 |
Cyp7a1 | Rat | sevoflurane | affects expression | EXP | | 6480464 | sevoflurane affects the expression of CYP7A1 mRNA | CTD | PMID:15967596 |
Cyp7a1 | Rat | simvastatin | multiple interactions | EXP | | 6480464 | Simvastatin promotes the reaction [Dietary Fats results in increased expression of CYP7A1 mRNA] and Simvastatin promotes the reaction [Dietary Fats results in increased expression of CYP7A1 protein] | CTD | PMID:33383043 |
Cyp7a1 | Rat | simvastatin | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | Simvastatin inhibits the reaction [osteum results in decreased expression of CYP7A1 mRNA] | CTD | PMID:33596472 |
Cyp7a1 | Rat | sodium arsenite | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CYP7A1 mRNA and sodium arsenite results in decreased expression of CYP7A1 protein | CTD | PMID:31532247 more ... |
Cyp7a1 | Rat | sodium arsenite | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | NR1H3 protein promotes the reaction [sodium arsenite results in decreased expression of CYP7A1 protein] and salvin inhibits the reaction [sodium arsenite results in decreased expression of CYP7A1 mRNA] | CTD | PMID:35202923 and PMID:37668303 |
Cyp7a1 | Rat | sodium arsenite | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CYP7A1 mRNA | CTD | PMID:29301061 |
Cyp7a1 | Rat | sodium cholate | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Sodium Cholate co-treated with Dietary Fats] results in decreased expression of CYP7A1 mRNA | CTD | PMID:23665937 |
Cyp7a1 | Rat | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of CYP7A1 mRNA | CTD | PMID:12325037 |
Cyp7a1 | Rat | Sodium oleate | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | Simvastatin inhibits the reaction [osteum results in decreased expression of CYP7A1 mRNA] | CTD | PMID:33596472 |
Cyp7a1 | Rat | Sodium oleate | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | osteum results in decreased expression of CYP7A1 mRNA | CTD | PMID:33596472 |
Cyp7a1 | Rat | soybean oil | increases activity | EXP | | 6480464 | Soybean Oil results in increased activity of CYP7A1 protein | CTD | PMID:12559476 |
Cyp7a1 | Rat | spironolactone | decreases activity | EXP | | 6480464 | Spironolactone results in decreased activity of CYP7A1 protein | CTD | PMID:15652244 |
Cyp7a1 | Rat | streptozocin | increases expression | EXP | | 6480464 | Streptozocin results in increased expression of CYP7A1 mRNA | CTD | PMID:10393316 |
Cyp7a1 | Rat | streptozocin | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Streptozocin results in increased expression of CYP7A1 mRNA | CTD | PMID:34896238 |
Cyp7a1 | Rat | streptozocin | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 mRNA more ... | CTD | PMID:29382564 and PMID:34896238 |
Cyp7a1 | Rat | streptozocin | multiple interactions | EXP | | 6480464 | [Dietary Fats co-treated with Streptozocin] results in decreased expression of CYP7A1 mRNA more ... | CTD | PMID:31100278 |
Cyp7a1 | Rat | sulfluramid | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | sulfluramid results in increased expression of CYP7A1 mRNA | CTD | PMID:35337807 |
Cyp7a1 | Rat | sulforaphane | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of CYP7A1 mRNA | CTD | PMID:34767876 |
Cyp7a1 | Rat | Sunset Yellow FCF | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP7A1 mRNA | CTD | PMID:33819548 |
Cyp7a1 | Rat | tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of CYP7A1 mRNA | CTD | PMID:19224547 |
Cyp7a1 | Rat | tamoxifen | affects expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of CYP7A1 mRNA | CTD | PMID:20937368 |
Cyp7a1 | Rat | tartrazine | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of CYP7A1 mRNA | CTD | PMID:33819548 |
Cyp7a1 | Rat | taurocholic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | FGFR4 protein affects the reaction [Taurocholic Acid results in decreased expression of CYP7A1 mRNA] and NR1H4 protein affects the reaction [Taurocholic Acid results in decreased expression of CYP7A1 mRNA] | CTD | PMID:16284190 |
Cyp7a1 | Rat | taurocholic acid | decreases expression | EXP | | 6480464 | Taurocholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:7832767 |
Cyp7a1 | Rat | taurocholic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Taurocholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:16284190 |
Cyp7a1 | Rat | tauroursodeoxycholic acid | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | ursodoxicoltaurine inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of CYP7A1 protein] | CTD | PMID:36787806 |
Cyp7a1 | Rat | tebuconazole | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | tebuconazole results in decreased expression of CYP7A1 mRNA | CTD | PMID:30458266 more ... |
Cyp7a1 | Rat | tectorigenin | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of CYP7A1 mRNA] and tectorigenin inhibits the reaction [Dietary Fats results in decreased expression of CYP7A1 protein] | CTD | PMID:35390440 |
Cyp7a1 | Rat | Tesaglitazar | decreases expression | EXP | | 6480464 | tesaglitazar results in decreased expression of CYP7A1 mRNA | CTD | PMID:21515302 |
Cyp7a1 | Rat | testosterone | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Testosterone results in decreased expression of CYP7A1 mRNA | CTD | PMID:21669218 |
Cyp7a1 | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA | CTD | PMID:19224547 and PMID:31150632 |
Cyp7a1 | Rat | tetrachloromethane | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | alisol B 23-acetate promotes the reaction [Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA] and Chenodeoxycholic Acid promotes the reaction [Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA] | CTD | PMID:25747392 |
Cyp7a1 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CYP7A1 mRNA | CTD | PMID:30723492 |
Cyp7a1 | Rat | tetrachloromethane | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CYP7A1 mRNA | CTD | PMID:29987408 |
Cyp7a1 | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | 1 more ... | CTD | PMID:31150632 and PMID:35872049 |
Cyp7a1 | Rat | tetrachloromethane | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of CYP7A1 mRNA | CTD | PMID:25747392 more ... |
Cyp7a1 | Rat | tetracycline | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Tetracycline results in increased expression of CYP7A1 mRNA | CTD | PMID:16917069 |
Cyp7a1 | Rat | tetracycline | decreases expression | EXP | | 6480464 | Tetracycline results in decreased expression of CYP7A1 mRNA | CTD | PMID:19224547 |
Cyp7a1 | Rat | Theaflavin 3,3'-digallate | affects expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | theaflavin-3 and 3'-digallate affects the expression of CYP7A1 mRNA | CTD | PMID:34925699 |
Cyp7a1 | Rat | thiacloprid | multiple interactions | EXP | | 6480464 | [thiacloprid co-treated with clothianidin] results in decreased expression of CYP7A1 mRNA and [thiacloprid co-treated with enilconazole] results in decreased expression of CYP7A1 mRNA | CTD | PMID:33426623 |
Cyp7a1 | Rat | thiacloprid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | thiacloprid results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | thiacloprid | decreases expression | EXP | | 6480464 | thiacloprid results in decreased expression of CYP7A1 mRNA | CTD | PMID:33426623 |
Cyp7a1 | Rat | thiamethoxam | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Thiamethoxam results in decreased expression of CYP7A1 protein | CTD | PMID:32194361 |
Cyp7a1 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CYP7A1 mRNA | CTD | PMID:26222700 |
Cyp7a1 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of CYP7A1 mRNA | CTD | PMID:34492290 |
Cyp7a1 | Rat | thiram | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Thiram results in decreased expression of CYP7A1 mRNA | CTD | PMID:32194361 |
Cyp7a1 | Rat | titanium dioxide | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of CYP7A1 mRNA | CTD | PMID:31298478 |
Cyp7a1 | Rat | titanium dioxide | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | Resveratrol promotes the reaction [titanium dioxide results in decreased expression of CYP7A1 mRNA] | CTD | PMID:31298478 |
Cyp7a1 | Rat | toluene | affects expression | EXP | | 6480464 | Toluene affects the expression of CYP7A1 mRNA | CTD | PMID:18653662 |
Cyp7a1 | Rat | tributylstannane | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | tributyltin results in increased expression of CYP7A1 mRNA | CTD | PMID:31939706 |
Cyp7a1 | Rat | Tributyltin oxide | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in decreased expression of CYP7A1 mRNA | CTD | PMID:18958704 |
Cyp7a1 | Rat | trichloroethene | increases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of CYP7A1 mRNA | CTD | PMID:19254012 |
Cyp7a1 | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of CYP7A1 mRNA | CTD | PMID:33387578 |
Cyp7a1 | Rat | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of CYP7A1 gene | CTD | PMID:27618143 |
Cyp7a1 | Rat | trichloroethene | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Trichloroethylene results in decreased expression of CYP7A1 mRNA | CTD | PMID:25549359 |
Cyp7a1 | Rat | triclosan | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Triclosan] results in decreased expression of CYP7A1 mRNA | CTD | PMID:33819548 |
Cyp7a1 | Rat | triclosan | affects expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Triclosan affects the expression of CYP7A1 mRNA | CTD | PMID:34681664 |
Cyp7a1 | Rat | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of CYP7A1 mRNA | CTD | PMID:30589522 |
Cyp7a1 | Rat | triphenyl phosphate | affects expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | triphenyl phosphate affects the expression of CYP7A1 mRNA | CTD | PMID:36563926 |
Cyp7a1 | Rat | Triptolide | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | triptolide results in decreased expression of CYP7A1 mRNA | CTD | PMID:32987112 |
Cyp7a1 | Rat | Triptolide | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [triptolide co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 protein more ... | CTD | PMID:32987112 and PMID:36328986 |
Cyp7a1 | Rat | tris(2-butoxyethyl) phosphate | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate results in decreased expression of CYP7A1 mRNA | CTD | PMID:29024780 |
Cyp7a1 | Rat | tris(2-chloroethyl) phosphate | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | tris(chloroethyl)phosphate results in decreased expression of CYP7A1 mRNA | CTD | PMID:35780845 |
Cyp7a1 | Rat | tris(2-chloroethyl) phosphate | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | Chenodeoxycholic Acid inhibits the reaction [tris(chloroethyl)phosphate results in decreased expression of CYP7A1 mRNA] | CTD | PMID:35780845 |
Cyp7a1 | Rat | troglitazone | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | troglitazone results in decreased expression of CYP7A1 mRNA | CTD | PMID:19631733 |
Cyp7a1 | Rat | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of CYP7A1 mRNA | CTD | PMID:21515302 |
Cyp7a1 | Rat | trovafloxacin | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [trovafloxacin co-treated with lipopolysaccharide and E coli O55-B5] results in decreased expression of CYP7A1 mRNA | CTD | PMID:18930950 |
Cyp7a1 | Rat | urethane | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Urethane results in decreased expression of CYP7A1 mRNA | CTD | PMID:28818685 |
Cyp7a1 | Rat | ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with Ursodeoxycholic Acid] results in decreased expression of CYP7A1 mRNA and Ursodeoxycholic Acid inhibits the reaction [Ethinyl Estradiol results in decreased expression of CYP7A1 mRNA] | CTD | PMID:16487557 and PMID:21274875 |
Cyp7a1 | Rat | ursodeoxycholic acid | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | Ursodeoxycholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:20671298 and PMID:25582706 |
Cyp7a1 | Rat | ursodeoxycholic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Ursodeoxycholic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:14684751 and PMID:21274875 |
Cyp7a1 | Rat | ursodeoxycholic acid | increases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in increased expression of CYP7A1 mRNA | CTD | PMID:16764892 |
Cyp7a1 | Rat | ursodeoxycholic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | Tretinoin promotes the reaction [Ursodeoxycholic Acid results in decreased expression of CYP7A1 mRNA] and Ursodeoxycholic Acid promotes the reaction [Tretinoin results in decreased expression of CYP7A1 mRNA] | CTD | PMID:21274875 |
Cyp7a1 | Rat | usnic acid | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CYP7A1 mRNA | CTD | PMID:22777745 |
Cyp7a1 | Rat | valdecoxib | decreases expression | EXP | | 6480464 | valdecoxib results in decreased expression of CYP7A1 mRNA | CTD | PMID:24136188 |
Cyp7a1 | Rat | valproic acid | decreases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CYP7A1 mRNA | CTD | PMID:29154799 and PMID:29501571 |
Cyp7a1 | Rat | vancomycin | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA] more ... | CTD | PMID:24657338 more ... |
Cyp7a1 | Rat | Yangonin | decreases expression | ISO | Cyp7a1 (Mus musculus) | 6480464 | yangonin results in decreased expression of CYP7A1 mRNA | CTD | PMID:29660435 |
Cyp7a1 | Rat | Yangonin | multiple interactions | ISO | Cyp7a1 (Mus musculus) | 6480464 | NR1H4 promotes the reaction [yangonin promotes the reaction [1-Naphthylisothiocyanate results in decreased expression of CYP7A1 mRNA]] more ... | CTD | PMID:29660435 |
Cyp7a1 | Rat | zinc atom | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CYP7A1 mRNA | CTD | PMID:16979875 |
Cyp7a1 | Rat | zinc atom | decreases activity | EXP | | 6480464 | Zinc results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |
Cyp7a1 | Rat | zinc atom | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Zinc deficiency results in increased expression of CYP7A1 mRNA | CTD | PMID:18356318 |
Cyp7a1 | Rat | zinc pyrithione | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | pyrithione zinc results in increased expression of CYP7A1 mRNA | CTD | PMID:21424779 |
Cyp7a1 | Rat | zinc(0) | multiple interactions | ISO | CYP7A1 (Homo sapiens) | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CYP7A1 mRNA | CTD | PMID:16979875 |
Cyp7a1 | Rat | zinc(0) | increases expression | ISO | CYP7A1 (Homo sapiens) | 6480464 | Zinc deficiency results in increased expression of CYP7A1 mRNA | CTD | PMID:18356318 |
Cyp7a1 | Rat | zinc(0) | decreases activity | EXP | | 6480464 | Zinc results in decreased activity of CYP7A1 protein | CTD | PMID:1175606 |